Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 930 of 1,261
  1. US 8137695

    Polyconjugates for in vivo delivery of polynucleotides

    Arrowhead Madison, Inc. · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  2. US 8137672

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  3. US 8138383

    Membrane active heteropolymers

    Arrowhead Madison, Inc. · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  4. US 8138312

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  5. US 8138310

    Chimeric CD154 polypeptides

    The Regents of the University of California · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  6. US 8138216

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  7. US 8138147

    Conditioned cell culture medium compositions and methods of use

    SkinMedica, Inc. · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  8. US 8137699

    Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  9. US 8138345

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  10. US 8138351

    Treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  11. US 8137960

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  12. US 8133904

    Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Jenrin Discovery, LLC · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  13. US 8133902

    Ammosamides as anticancer agents

    The Regents of the University of California · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  14. US 8133894

    N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones

    Akebia Therapeutics, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  15. US 8133870

    Therapeutic furopyrimidines and thienopyrimidines

    BioCryst Pharmaceuticals, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  16. US 8133865

    von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  17. US 8133861

    Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

    Alseres Pharmaceuticals, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  18. US 8133495

    Live attenuated antigenically marked classical swine fever virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  19. US 8133496

    Compositions and methods for diagnosing and treating urinary tract infections

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  20. US 8133915

    Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators

    The Regents of the University of California · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  21. US 8133905

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  22. US 8133859

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  23. US 8133917

    Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  24. US 8134006

    Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.